← Back to Clinical Trials
Recruiting NCT06894238

NCT06894238 Electroencephalogram Predicts Post-operative Delirium

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06894238
Status Recruiting
Phase
Sponsor Beijing Sanbo Brain Hospital
Condition Neurosurgery
Study Type OBSERVATIONAL
Enrollment 137 participants
Start Date 2025-03-01
Primary Completion 2026-03-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Sub-hairline EEG Monitoring

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 137 participants in total. It began in 2025-03-01 with a primary completion date of 2026-03-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this observational study is to investigate the predictive value of sub-hairline electroencephalography (EEG) during anesthesia recovery for postoperative delirium (POD). The main question to be answered is: * Can sub-hairline EEG measured during anesthesia recovery serve as a reliable predictor of POD? Adult patients undergoing elective craniotomy and admitted to the ICU will be enrolled. Sub-hairline EEG will be monitored until ICU discharge.

Eligibility Criteria

Inclusion Criteria: * Age ≥ 18 years * Planned elective neurosurgical surgery * ASA physical status I-II * Signed informed consent Exclusion Criteria: * Known neurological or psychiatric disorders (e.g., epilepsy, Parkinson's disease) * Preoperative cognitive impairment (MMSE score \< 24) * Long-term use of central nervous system drugs (e.g., antidepressants, antipsychotics) * Language barriers * History of craniotomy within the last 12 months * Inability to place frontal-temporal electrodes due to conditions such as frontal skin injury, severe agitation, or a coronal incision for surgery * Pregnant or breastfeeding women

Contact & Investigator

Central Contact

Zhonghua Shi, PhD,MD

✉ z.shi@mail.ccmu.edu.cn

📞 010-62856764

Principal Investigator

Zhonghua Shi, PhD,MD

PRINCIPAL INVESTIGATOR

Capital Medical University

Frequently Asked Questions

Who can join the NCT06894238 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Neurosurgery. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06894238 currently recruiting?

Yes, NCT06894238 is actively recruiting participants. Contact the research team at z.shi@mail.ccmu.edu.cn for enrollment information.

Where is the NCT06894238 trial being conducted?

This trial is being conducted at Beijing, China, Beijing, China.

Who is sponsoring the NCT06894238 clinical trial?

NCT06894238 is sponsored by Beijing Sanbo Brain Hospital. The principal investigator is Zhonghua Shi, PhD,MD at Capital Medical University. The trial plans to enroll 137 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology